ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Polio Vaccines Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-1Y11521
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Polio Vaccines Market Research Report 2022
BUY CHAPTERS

Global Polio Vaccines Market Research Report 2025

Code: QYRE-Auto-1Y11521
Report
September 2025
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
CSL Limited
GlaxoSmithKline PLC
Johnson & Johnson
MedImmune
Merck
Pfizer Inc
Sanofi Pasteur
Serum Institute

Polio Vaccines Market Size

The global market for Polio Vaccines was valued at US$ 744 million in the year 2024 and is projected to reach a revised size of US$ 870 million by 2031, growing at a CAGR of 2.3% during the forecast period.

Polio Vaccines Market

Polio Vaccines Market

Polio vaccines are vaccines used to prevent poliomyelitis. There are two types: one that uses inactivated poliovirus and is given by injection, and one that uses weakened poliovirus and is given by mouth.
The World Health Organization recommends all children be fully vaccinated against polio. The two vaccines have eliminated polio from most of the world, and reduced the number of cases reported each year from an estimated 350,000 in 1988 to 37 in 2023.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Polio Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Polio Vaccines.
The Polio Vaccines market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Polio Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Polio Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Polio Vaccines Market Report

Report Metric Details
Report Name Polio Vaccines Market
Accounted market size in year US$ 744 million
Forecasted market size in 2031 US$ 870 million
CAGR 2.3%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • IPV
  • OPV
Segment by Application
  • Age (0-1)
  • Age Above 1
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company CSL, GlaxoSmithKline, Johnson & Johnson, MedImmune, Merck, Pfizer, Sanofi Pasteur, Serum Institute
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Polio Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Polio Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Polio Vaccines Market growing?

Ans: The Polio Vaccines Market witnessing a CAGR of 2.3% during the forecast period 2025-2031.

What is the Polio Vaccines Market size in 2031?

Ans: The Polio Vaccines Market size in 2031 will be US$ 870 million.

Who are the main players in the Polio Vaccines Market report?

Ans: The main players in the Polio Vaccines Market are CSL, GlaxoSmithKline, Johnson & Johnson, MedImmune, Merck, Pfizer, Sanofi Pasteur, Serum Institute

What are the Application segmentation covered in the Polio Vaccines Market report?

Ans: The Applications covered in the Polio Vaccines Market report are Age (0-1), Age Above 1

What are the Type segmentation covered in the Polio Vaccines Market report?

Ans: The Types covered in the Polio Vaccines Market report are IPV, OPV

1 Polio Vaccines Market Overview
1.1 Product Definition
1.2 Polio Vaccines by Type
1.2.1 Global Polio Vaccines Market Value Comparison by Type (2024 VS 2031)
1.2.2 IPV
1.2.3 OPV
1.3 Polio Vaccines by Application
1.3.1 Global Polio Vaccines Market Value by Application (2024 VS 2031)
1.3.2 Age (0-1)
1.3.3 Age Above 1
1.4 Global Polio Vaccines Market Size Estimates and Forecasts
1.4.1 Global Polio Vaccines Revenue 2020-2031
1.4.2 Global Polio Vaccines Sales 2020-2031
1.4.3 Global Polio Vaccines Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Polio Vaccines Market Competition by Manufacturers
2.1 Global Polio Vaccines Sales Market Share by Manufacturers (2020-2025)
2.2 Global Polio Vaccines Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Polio Vaccines Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Polio Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Polio Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Polio Vaccines, Product Type & Application
2.7 Global Key Manufacturers of Polio Vaccines, Date of Enter into This Industry
2.8 Global Polio Vaccines Market Competitive Situation and Trends
2.8.1 Global Polio Vaccines Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Polio Vaccines Players Market Share by Revenue
2.8.3 Global Polio Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Polio Vaccines Market Scenario by Region
3.1 Global Polio Vaccines Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Polio Vaccines Sales by Region: 2020-2031
3.2.1 Global Polio Vaccines Sales by Region: 2020-2025
3.2.2 Global Polio Vaccines Sales by Region: 2026-2031
3.3 Global Polio Vaccines Revenue by Region: 2020-2031
3.3.1 Global Polio Vaccines Revenue by Region: 2020-2025
3.3.2 Global Polio Vaccines Revenue by Region: 2026-2031
3.4 North America Polio Vaccines Market Facts & Figures by Country
3.4.1 North America Polio Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Polio Vaccines Sales by Country (2020-2031)
3.4.3 North America Polio Vaccines Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Polio Vaccines Market Facts & Figures by Country
3.5.1 Europe Polio Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Polio Vaccines Sales by Country (2020-2031)
3.5.3 Europe Polio Vaccines Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Polio Vaccines Market Facts & Figures by Region
3.6.1 Asia Pacific Polio Vaccines Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Polio Vaccines Sales by Region (2020-2031)
3.6.3 Asia Pacific Polio Vaccines Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Polio Vaccines Market Facts & Figures by Country
3.7.1 Latin America Polio Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Polio Vaccines Sales by Country (2020-2031)
3.7.3 Latin America Polio Vaccines Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Polio Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Polio Vaccines Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Polio Vaccines Sales by Country (2020-2031)
3.8.3 Middle East and Africa Polio Vaccines Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Polio Vaccines Sales by Type (2020-2031)
4.1.1 Global Polio Vaccines Sales by Type (2020-2025)
4.1.2 Global Polio Vaccines Sales by Type (2026-2031)
4.1.3 Global Polio Vaccines Sales Market Share by Type (2020-2031)
4.2 Global Polio Vaccines Revenue by Type (2020-2031)
4.2.1 Global Polio Vaccines Revenue by Type (2020-2025)
4.2.2 Global Polio Vaccines Revenue by Type (2026-2031)
4.2.3 Global Polio Vaccines Revenue Market Share by Type (2020-2031)
4.3 Global Polio Vaccines Price by Type (2020-2031)
5 Segment by Application
5.1 Global Polio Vaccines Sales by Application (2020-2031)
5.1.1 Global Polio Vaccines Sales by Application (2020-2025)
5.1.2 Global Polio Vaccines Sales by Application (2026-2031)
5.1.3 Global Polio Vaccines Sales Market Share by Application (2020-2031)
5.2 Global Polio Vaccines Revenue by Application (2020-2031)
5.2.1 Global Polio Vaccines Revenue by Application (2020-2025)
5.2.2 Global Polio Vaccines Revenue by Application (2026-2031)
5.2.3 Global Polio Vaccines Revenue Market Share by Application (2020-2031)
5.3 Global Polio Vaccines Price by Application (2020-2031)
6 Key Companies Profiled
6.1 CSL
6.1.1 CSL Company Information
6.1.2 CSL Description and Business Overview
6.1.3 CSL Polio Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.1.4 CSL Polio Vaccines Product Portfolio
6.1.5 CSL Recent Developments/Updates
6.2 GlaxoSmithKline
6.2.1 GlaxoSmithKline Company Information
6.2.2 GlaxoSmithKline Description and Business Overview
6.2.3 GlaxoSmithKline Polio Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.2.4 GlaxoSmithKline Polio Vaccines Product Portfolio
6.2.5 GlaxoSmithKline Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Company Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Polio Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Johnson & Johnson Polio Vaccines Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 MedImmune
6.4.1 MedImmune Company Information
6.4.2 MedImmune Description and Business Overview
6.4.3 MedImmune Polio Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.4.4 MedImmune Polio Vaccines Product Portfolio
6.4.5 MedImmune Recent Developments/Updates
6.5 Merck
6.5.1 Merck Company Information
6.5.2 Merck Description and Business Overview
6.5.3 Merck Polio Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Merck Polio Vaccines Product Portfolio
6.5.5 Merck Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Company Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Polio Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Pfizer Polio Vaccines Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Sanofi Pasteur
6.7.1 Sanofi Pasteur Company Information
6.7.2 Sanofi Pasteur Description and Business Overview
6.7.3 Sanofi Pasteur Polio Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sanofi Pasteur Polio Vaccines Product Portfolio
6.7.5 Sanofi Pasteur Recent Developments/Updates
6.8 Serum Institute
6.8.1 Serum Institute Company Information
6.8.2 Serum Institute Description and Business Overview
6.8.3 Serum Institute Polio Vaccines Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Serum Institute Polio Vaccines Product Portfolio
6.8.5 Serum Institute Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Polio Vaccines Industry Chain Analysis
7.2 Polio Vaccines Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Polio Vaccines Production Mode & Process Analysis
7.4 Polio Vaccines Sales and Marketing
7.4.1 Polio Vaccines Sales Channels
7.4.2 Polio Vaccines Distributors
7.5 Polio Vaccines Customer Analysis
8 Polio Vaccines Market Dynamics
8.1 Polio Vaccines Industry Trends
8.2 Polio Vaccines Market Drivers
8.3 Polio Vaccines Market Challenges
8.4 Polio Vaccines Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
CSL Limited
GlaxoSmithKline PLC
Johnson & Johnson
MedImmune
Merck
Pfizer Inc
Sanofi Pasteur
Serum Institute
List of Tables
 Table 1. Global Polio Vaccines Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Polio Vaccines Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Polio Vaccines Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Polio Vaccines Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Polio Vaccines Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Polio Vaccines Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Polio Vaccines Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Polio Vaccines Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Polio Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Polio Vaccines, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Polio Vaccines, Product Type & Application
 Table 12. Global Key Manufacturers of Polio Vaccines, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Polio Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Polio Vaccines as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Polio Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Polio Vaccines Sales by Region (2020-2025) & (K Units)
 Table 18. Global Polio Vaccines Sales Market Share by Region (2020-2025)
 Table 19. Global Polio Vaccines Sales by Region (2026-2031) & (K Units)
 Table 20. Global Polio Vaccines Sales Market Share by Region (2026-2031)
 Table 21. Global Polio Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Polio Vaccines Revenue Market Share by Region (2020-2025)
 Table 23. Global Polio Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Polio Vaccines Revenue Market Share by Region (2026-2031)
 Table 25. North America Polio Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Polio Vaccines Sales by Country (2020-2025) & (K Units)
 Table 27. North America Polio Vaccines Sales by Country (2026-2031) & (K Units)
 Table 28. North America Polio Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Polio Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Polio Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Polio Vaccines Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Polio Vaccines Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Polio Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Polio Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Polio Vaccines Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Polio Vaccines Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Polio Vaccines Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Polio Vaccines Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Polio Vaccines Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Polio Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Polio Vaccines Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Polio Vaccines Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Polio Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Polio Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Polio Vaccines Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Polio Vaccines Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Polio Vaccines Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Polio Vaccines Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Polio Vaccines Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Polio Vaccines Sales (K Units) by Type (2020-2025)
 Table 51. Global Polio Vaccines Sales (K Units) by Type (2026-2031)
 Table 52. Global Polio Vaccines Sales Market Share by Type (2020-2025)
 Table 53. Global Polio Vaccines Sales Market Share by Type (2026-2031)
 Table 54. Global Polio Vaccines Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Polio Vaccines Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Polio Vaccines Revenue Market Share by Type (2020-2025)
 Table 57. Global Polio Vaccines Revenue Market Share by Type (2026-2031)
 Table 58. Global Polio Vaccines Price (USD/Unit) by Type (2020-2025)
 Table 59. Global Polio Vaccines Price (USD/Unit) by Type (2026-2031)
 Table 60. Global Polio Vaccines Sales (K Units) by Application (2020-2025)
 Table 61. Global Polio Vaccines Sales (K Units) by Application (2026-2031)
 Table 62. Global Polio Vaccines Sales Market Share by Application (2020-2025)
 Table 63. Global Polio Vaccines Sales Market Share by Application (2026-2031)
 Table 64. Global Polio Vaccines Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Polio Vaccines Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Polio Vaccines Revenue Market Share by Application (2020-2025)
 Table 67. Global Polio Vaccines Revenue Market Share by Application (2026-2031)
 Table 68. Global Polio Vaccines Price (USD/Unit) by Application (2020-2025)
 Table 69. Global Polio Vaccines Price (USD/Unit) by Application (2026-2031)
 Table 70. CSL Company Information
 Table 71. CSL Description and Business Overview
 Table 72. CSL Polio Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. CSL Polio Vaccines Product
 Table 74. CSL Recent Developments/Updates
 Table 75. GlaxoSmithKline Company Information
 Table 76. GlaxoSmithKline Description and Business Overview
 Table 77. GlaxoSmithKline Polio Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. GlaxoSmithKline Polio Vaccines Product
 Table 79. GlaxoSmithKline Recent Developments/Updates
 Table 80. Johnson & Johnson Company Information
 Table 81. Johnson & Johnson Description and Business Overview
 Table 82. Johnson & Johnson Polio Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Johnson & Johnson Polio Vaccines Product
 Table 84. Johnson & Johnson Recent Developments/Updates
 Table 85. MedImmune Company Information
 Table 86. MedImmune Description and Business Overview
 Table 87. MedImmune Polio Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. MedImmune Polio Vaccines Product
 Table 89. MedImmune Recent Developments/Updates
 Table 90. Merck Company Information
 Table 91. Merck Description and Business Overview
 Table 92. Merck Polio Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Merck Polio Vaccines Product
 Table 94. Merck Recent Developments/Updates
 Table 95. Pfizer Company Information
 Table 96. Pfizer Description and Business Overview
 Table 97. Pfizer Polio Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. Pfizer Polio Vaccines Product
 Table 99. Pfizer Recent Developments/Updates
 Table 100. Sanofi Pasteur Company Information
 Table 101. Sanofi Pasteur Description and Business Overview
 Table 102. Sanofi Pasteur Polio Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Sanofi Pasteur Polio Vaccines Product
 Table 104. Sanofi Pasteur Recent Developments/Updates
 Table 105. Serum Institute Company Information
 Table 106. Serum Institute Description and Business Overview
 Table 107. Serum Institute Polio Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Serum Institute Polio Vaccines Product
 Table 109. Serum Institute Recent Developments/Updates
 Table 110. Key Raw Materials Lists
 Table 111. Raw Materials Key Suppliers Lists
 Table 112. Polio Vaccines Distributors List
 Table 113. Polio Vaccines Customers List
 Table 114. Polio Vaccines Market Trends
 Table 115. Polio Vaccines Market Drivers
 Table 116. Polio Vaccines Market Challenges
 Table 117. Polio Vaccines Market Restraints
 Table 118. Research Programs/Design for This Report
 Table 119. Key Data Information from Secondary Sources
 Table 120. Key Data Information from Primary Sources
 Table 121. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Polio Vaccines
 Figure 2. Global Polio Vaccines Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Polio Vaccines Market Share by Type: 2024 & 2031
 Figure 4. IPV Product Picture
 Figure 5. OPV Product Picture
 Figure 6. Global Polio Vaccines Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Polio Vaccines Market Share by Application: 2024 & 2031
 Figure 8. Age (0-1)
 Figure 9. Age Above 1
 Figure 10. Global Polio Vaccines Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 11. Global Polio Vaccines Market Size (2020-2031) & (US$ Million)
 Figure 12. Global Polio Vaccines Sales (2020-2031) & (K Units)
 Figure 13. Global Polio Vaccines Average Price (USD/Unit) & (2020-2031)
 Figure 14. Polio Vaccines Report Years Considered
 Figure 15. Polio Vaccines Sales Share by Manufacturers in 2024
 Figure 16. Global Polio Vaccines Revenue Share by Manufacturers in 2024
 Figure 17. Global 5 and 10 Largest Polio Vaccines Players: Market Share by Revenue in Polio Vaccines in 2024
 Figure 18. Polio Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 19. Global Polio Vaccines Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 20. North America Polio Vaccines Sales Market Share by Country (2020-2031)
 Figure 21. North America Polio Vaccines Revenue Market Share by Country (2020-2031)
 Figure 22. U.S. Polio Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 23. Canada Polio Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Europe Polio Vaccines Sales Market Share by Country (2020-2031)
 Figure 25. Europe Polio Vaccines Revenue Market Share by Country (2020-2031)
 Figure 26. Germany Polio Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. France Polio Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. U.K. Polio Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Italy Polio Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Russia Polio Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Asia Pacific Polio Vaccines Sales Market Share by Region (2020-2031)
 Figure 32. Asia Pacific Polio Vaccines Revenue Market Share by Region (2020-2031)
 Figure 33. China Polio Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Japan Polio Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. South Korea Polio Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. India Polio Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Australia Polio Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Taiwan Polio Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Indonesia Polio Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Thailand Polio Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Malaysia Polio Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Philippines Polio Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Polio Vaccines Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Polio Vaccines Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Polio Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Polio Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Polio Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Polio Vaccines Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Polio Vaccines Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Polio Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Polio Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. U.A.E Polio Vaccines Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Polio Vaccines by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Polio Vaccines by Type (2020-2031)
 Figure 55. Global Polio Vaccines Price (USD/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Polio Vaccines by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Polio Vaccines by Application (2020-2031)
 Figure 58. Global Polio Vaccines Price (USD/Unit) by Application (2020-2031)
 Figure 59. Polio Vaccines Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novocure

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions